301 related articles for article (PubMed ID: 23828241)
1. High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance.
Wu ZB; Cai L; Lin SJ; Xiong ZK; Lu JL; Mao Y; Yao Y; Zhou LF
Neuro Oncol; 2013 Sep; 15(9):1264-75. PubMed ID: 23828241
[TBL] [Abstract][Full Text] [Related]
2. Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A.
Cai L; Li Q; Li W; Wang C; Tu M; Zhu Z; Su Z; Lu X
Int J Clin Oncol; 2020 Jun; 25(6):1055-1066. PubMed ID: 32103382
[TBL] [Abstract][Full Text] [Related]
3. Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells.
Wu L; Yang L; Xiong Y; Guo H; Shen X; Cheng Z; Zhang Y; Gao Z; Zhu X
Tumour Biol; 2014 Dec; 35(12):12327-37. PubMed ID: 25245332
[TBL] [Abstract][Full Text] [Related]
4. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
Cheng P; Ma Y; Gao Z; Duan L
Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
[TBL] [Abstract][Full Text] [Related]
5. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
[TBL] [Abstract][Full Text] [Related]
6. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
7. Endosome associated trafficking regulator 1 promotes tumor growth and invasion of glioblastoma multiforme via inhibiting TNF signaling pathway.
Zhang Q; Dai Z; Chen Y; Li Q; Guo Y; Zhu Z; Tu M; Cai L; Lu X
J Neurooncol; 2024 Jan; 166(1):113-127. PubMed ID: 38191954
[TBL] [Abstract][Full Text] [Related]
8. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
Sun J; Zhao B; Du K; Liu P
Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma.
Kwon JH; Kim J; Park JY; Hong SM; Park CW; Hong SJ; Park SY; Choi YJ; Do IG; Joh JW; Kim DS; Choi KY
Clin Cancer Res; 2010 Nov; 16(22):5511-21. PubMed ID: 20851854
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
12. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
13. SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance.
Yu F; Li G; Gao J; Sun Y; Liu P; Gao H; Li P; Lei T; Chen Y; Cheng Y; Zhai X; Sayari AJ; Huang H; Mu Q
Cell Prolif; 2016 Apr; 49(2):195-206. PubMed ID: 26923184
[TBL] [Abstract][Full Text] [Related]
14. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
[TBL] [Abstract][Full Text] [Related]
15. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
16. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
[TBL] [Abstract][Full Text] [Related]
17. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
18. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
[TBL] [Abstract][Full Text] [Related]
19. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
20. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
